Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06337214
Other study ID # TCHIRB-11301014-E
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 13, 2024
Est. completion date February 28, 2025

Study information

Verified date April 2024
Source Taipei City Hospital
Contact Yu-Hsuan Tai, MD
Phone +886918130891
Email daidayangisele@gmail.com, DBB02@tpech.gov.tw
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to evaluate the impact of the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" on patients with breast cancer who are currently undergoing conventional Western medical treatments in Taiwan. The main questions it aims to answer are: Can the "Traditional Chinese Medicine Therapy Program" alleviate symptoms experienced by breast cancer patients? Does the program improve the quality of life for breast cancer patients receiving Western medical treatments? How does the program contribute to the management of side effects associated with Western oncological therapies? Participants will: Engage in the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" provided by the Taiwan Compassionate Cancer Care Association. Receive supportive and educational services, including auxiliary Chinese medicine treatment courses, lifestyle and health education, and psychological counseling. This study seeks to integrate the concept of holistic healthcare, emphasizing coordinated care that encompasses physical, mental, and social aspects, into the treatment of breast cancer.


Description:

This study aims to evaluate whether the participation in Traditional Chinese Medicine (TCM) supportive therapy courses, specifically the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" combined with the use of the herbal formulation at Taipei City Hospital, can enhance the quality of life of breast cancer patients undergoing treatment, increase their understanding and satisfaction with TCM adjunctive treatments, and bolster their confidence in cancer recovery. This study adopts a holistic healthcare approach, integrating the Traditional Chinese Medicine (TCM) formulation Kuan-Sin-Yin from Taipei City Hospital with the "TCM Therapy Program for Reinforcing Vital Energy" course offered by a cancer patient support organization, to research its effects on breast cancer patients undergoing conventional medical treatment. International standard questionnaires and other inquiries are utilized to evaluate the impact on patients' physical, emotional, spiritual, and social well-being.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date February 28, 2025
Est. primary completion date February 28, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study. - Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine. - Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy. Exclusion Criteria: - Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine. - Patients regularly receiving Astragalus polysaccharide injections. - Patients with a history of allergies to Traditional Chinese Medicine. - Pregnant or breastfeeding women. - Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs. - Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form).

Study Design


Intervention

Behavioral:
Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy
Comparing cancer patients who have participated in the program with those who have not, this study will examine differences in two types of quality of life questionnaires and constitution between the two groups.

Locations

Country Name City State
Taiwan Taipei City Hospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Taipei City Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Questionnaire: Constitution in Chinese Medicine Questionnaire Observation and analysis Traditional Chinese Medicine Constitutions in breast cancer undergoing treatment Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks
Primary Questionnaire: Functional Assessment of Cancer Therapy-General Scale, FACT-G)(Version 4) Observation and analysis to measure four domains of QoL in cancer patients: Physical, social, emotional, and functional well-being Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks
Primary Questionnaire: European Organisation for Research and Treatment of Cancer, EORTC QLQ-BR23) Observation and analysis for measuring the quality of life in patients with breast cancer Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks
Secondary Additional questions regarding the "Traditional Chinese Medicine Program for Reinforcing Vital Energy" Understanding and Course satisfaction and Confidence in cancer recovery Pre-test ? Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not ? Post-test After 4 ~6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2